126 related articles for article (PubMed ID: 34030621)
1. sFRP1 Expression Regulates Wnt Signaling in Chronic Myeloid Leukemia K562 Cells.
Pehlivan M; Caliskan C; Yuce Z; Sercan HO
Anticancer Agents Med Chem; 2022; 22(7):1354-1362. PubMed ID: 34030621
[TBL] [Abstract][Full Text] [Related]
2. sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.
Pehlivan M; Sercan Z; Sercan HO
Leuk Res; 2009 Aug; 33(8):1062-7. PubMed ID: 19118898
[TBL] [Abstract][Full Text] [Related]
3. Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors.
Pehlivan M; Caliskan C; Yuce Z; Sercan HO
Tumour Biol; 2017 May; 39(5):1010428317701654. PubMed ID: 28468589
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
[TBL] [Abstract][Full Text] [Related]
5. [sFRP1 Expression Induces miRNAs That Modulate Wnt Signaling in Chronic Myeloid Leukemia Cells].
Pehlivan M; Soyoz M; Cerci B; Coven HIK; Yuce Z; Sercan HO
Mol Biol (Mosk); 2020; 54(4):626-633. PubMed ID: 32799225
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
7. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
8. Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line.
Demirkiran N; Aydin B; Pehlivan M; Yuce Z; Sercan HO
Med Oncol; 2024 Apr; 41(5):109. PubMed ID: 38592567
[TBL] [Abstract][Full Text] [Related]
9. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
11. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.
Corrêa S; Binato R; Du Rocher B; Castelo-Branco MT; Pizzatti L; Abdelhay E
BMC Cancer; 2012 Jul; 12():303. PubMed ID: 22823957
[TBL] [Abstract][Full Text] [Related]
13. sFRP1 protects H9c2 cardiac myoblasts from doxorubicin-induced apoptosis by inhibiting the Wnt/PCP-JNK pathway.
Hu YH; Liu J; Lu J; Wang PX; Chen JX; Guo Y; Han FH; Wang JJ; Li W; Liu PQ
Acta Pharmacol Sin; 2020 Sep; 41(9):1150-1157. PubMed ID: 32238888
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
[TBL] [Abstract][Full Text] [Related]
15. Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia.
Cheng CK; Li L; Cheng SH; Ng K; Chan NP; Ip RK; Wong RS; Shing MM; Li CK; Ng MH
Blood; 2011 Dec; 118(25):6638-48. PubMed ID: 22031861
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
17. Effects of supplementation with nondigestible carbohydrates on fecal calprotectin and on epigenetic regulation of SFRP1 expression in the large-bowel mucosa of healthy individuals.
Malcomson FC; Willis ND; McCallum I; Xie L; Ibero-Baraibar I; Leung WC; Kelly S; Bradburn DM; Belshaw NJ; Johnson IT; Mathers JC
Am J Clin Nutr; 2017 Feb; 105(2):400-410. PubMed ID: 28077379
[TBL] [Abstract][Full Text] [Related]
18. Dvl proteins regulate SMAD1, AHR, mTOR, BRD7 protein expression while differentially regulating canonical and non-canonical Wnt signaling pathways in CML cell lines.
Caliskan C; Yuce Z; Ogun Sercan H
Gene; 2023 Feb; 854():147109. PubMed ID: 36509295
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled related protein 1 protects H9C2 cells from hypoxia/re-oxygenation injury by blocking the Wnt signaling pathway.
Tao J; Abudoukelimu M; Ma YT; Yang YN; Li XM; Chen BD; Liu F; He CH; Li HY
Lipids Health Dis; 2016 Apr; 15():72. PubMed ID: 27048460
[TBL] [Abstract][Full Text] [Related]
20. Morphine activates blast-phase chronic myeloid leukemia cells and alleviates the effects of tyrosine kinase inhibitors.
Zhou Z; Liu T; Zhang J
Biochem Biophys Res Commun; 2019 Dec; 520(3):560-565. PubMed ID: 31615652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
